Format

Send to

Choose Destination
Eur J Clin Pharmacol. 2017 Nov;73(11):1389-1398. doi: 10.1007/s00228-017-2314-3. Epub 2017 Aug 5.

Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.

Author information

1
Department of Pharmacy, Mataró Hospital, Mataró, Spain. mmiarons@csdm.cat.
2
Gastrointestinal Physiology Laboratory, Mataró Hospital, Mataró, Spain.
3
Department of Psychiatry, Mataró Hospital, Mataró, Spain.
4
Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas (CIBERehd), Instituto de Salud Carlos III, Barcelona, Spain.

Abstract

PURPOSE:

Antipsychotics (APs) are commonly used to manage neuropsychiatric symptoms (NPS) in elderly patients with dementia, even though several large studies have demonstrated an association between AP treatment and increased morbidity and mortality in people with dementia. The aim of this study is to review the scientific literature of the use of AP in the elderly with dementia and to propose an algorithm to assist in decision-making regarding the withdrawal of APs.

METHODS:

A computerized literature search (MEDLINE: 1966 to December 2016, EMBASE: 1982 to December 2016) was used to locate relevant literature. Keywords in the search included terms from Medical Subject Headings (MESH) and EMBASE thesaurus (EMTREE). The following terms were used in the MESH database and EMTREE thesaurus: Aged, Antipsychotic Agents, Behavioral Symptoms and Dementia.

RESULTS:

Earlier studies of APs used in elderly patients with dementia suggest that, in most elderly demented patients, APs can be withdrawn with no effect on behaviour. These patients are likely to benefit from the algorithm we propose to assist clinicians in the withdrawal of APs.

CONCLUSIONS:

In this paper, we review the potential risks and benefits of discontinuing AP treatment in elderly demented patients with NPS and propose an algorithm to assist in decision-making regarding AP withdrawal.

KEYWORDS:

Aged; Algorithm; Antipsychotic agents; Behavioural symptoms; Dementia; Drug-related side effects and adverse reactions

PMID:
28780696
DOI:
10.1007/s00228-017-2314-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center